Tesla BioHealing Biophoton Generators (BioHealer / Tesla MedBed Generator)

device · 2019–present

category:device

delivery:Sealed, opaque metal canisters (roughly 3.5 x 4 inches for the consumer 'BioHealer,' larger for the 'MedBed Generator') that the company says passively emit a field of 'Biophoton Life Force Energy.' Marketed instructions direct buyers to place a canister within about three feet of the affected body part for at least eight hours a day, often overnight. The company also operates branded 'MedBed' wellness-hotel centers where dozens of the canisters are built into hotel-room bed frames and, at one location, submerged in the swimming pool, so guests are continuously near the devices during a paid overnight stay.

price tier:premium · 2023–2024

era:2019–present

current status:current

regulatory:grey_market

SHORT PITCH (AS SOLD)

Sealed canisters that the seller says concentrate the body's own 'biophoton' light into a therapeutic 'Life Force Energy' field, sold direct-to-consumer and installed in company-run 'MedBed' wellness-hotel rooms, marketed as helping conditions from chronic pain to terminal cancer, stroke paralysis, and dementia.

THE ACTUAL EVIDENCE

Biophotons -- ultra-weak light naturally emitted by living tissue -- are a real, measured phenomenon, but Bahman Anvari, a professor of bioengineering at UC Riverside, told the Associated Press (31 January 2024) that their role in health is not well understood and their use as a medical therapy is not proven. No controlled clinical trial of the Tesla BioHealer or MedBed Generator against any disease endpoint has been published in the sources reviewed for this case; the evidentiary basis offered by the company itself is uncontrolled user testimonials, credited by the company's own website (quoted in its August 2023 FDA warning letter) to 'Based on the trends we have seen with over 20,000 people using Tesla BioHealing technology to date.' The FDA's inspection found the devices adulterated (marketed without the premarket approval or investigational-device exemption required for a device of this kind) and misbranded (marketed for uses -- including terminal cancers, stroke paralysis, Lyme disease, Alzheimer's/dementia, and epilepsy -- far beyond the narrow infrared-lamp heating-pad exemption under which the devices were registered, despite having no heating element at all), on top of multiple manufacturing quality-system violations. No FDA close-out letter resolving the warning letter was found. A registered study of the device (ClinicalTrials.gov NCT06855459, 'The Impact of Biophoton Therapy on Self-Grown Stem Cells'), run at Tesla facilities in Tampa, FL and Butler, PA, was marked completed in April 2026, but the registry carries no posted results, so no trial outcomes for the device have been posted to that registry.

PRACTITIONERS

Tesla BioHealing, Inc.

CASES

liu-tesla-biohealing-2019-present

CLAIMS

Tesla BioHealing's 'Intended Use Chart' and promotional materials list the MedBed Generator and BioHealer as intended for 'Severe Conditions' including terminal cancers, stroke paralysis, intense chronic debilitating pain, gout, arthritis, and traumatic brain injury, and for 'Moderate Conditions' including Lyme disease, COPD, Alzheimer's/dementia, epilepsy/seizure disorders, erectile dysfunction, and infertility, with specific canister-placement instructions for each. unreplicated
The company's canisters generate a concentrated field of 'Biophoton Life Force Energy' -- a natural healing force also produced by living cells themselves -- that the body can use to activate faster, more profound cellular self-repair. unreplicated
Based on trends the company says it has observed with over 20,000 product users, early signs of the devices' efficacy include pain reduction, better sleep, vivid dreams, increased vitality, increased libido, improved digestion, easier breathing, increased mental clarity, and normalized glucose and blood-pressure levels, with further condition-specific improvements (including increased mobility in previously paralyzed limbs and ceasing of tremors) reported for brain-based conditions. untested

SOURCES

NOTES

Tesla BioHealing, Inc. began selling its “BioHealer” canisters directly to consumers in 2019. By August 2024, a year after its FDA warning letter, The Skeptic reported the company operating eight MedBed wellness-hotel centers nationwide; the company’s own site lists the same eight (Butler, PA; Milford, DE; Kearny, AZ; East Dubuque, IL; Tampa, FL; Leesburg, FL; Woburn, MA; and Hot Springs, AR) as of July 2026. The product line runs from a $599 basic canister through a $19,999-per-pair “MedBed Generator,” alongside a “StemRenew” system and other accessories, all pitched on the same underlying claim: that the devices emit a concentrated field of “Biophoton Life Force Energy” that lets the body’s cells “self-repair” faster than they otherwise could. Every marketing page carries a disclaimer that the FDA-registered, over-the-counter devices are “not intended to diagnose, treat, cure, or prevent any disease or medical condition” — language that sits beside an “Intended Use Chart,” quoted directly in the FDA’s 2023 warning letter, instructing buyers where to place the canisters for “Severe Conditions” including “Terminal Cancers, Stroke-Paralysis,” “Traumatic Brain Injury,” and more. The FDA concluded the devices are adulterated and misbranded and cited the firm for a list of Quality System regulation violations; the company continued selling afterward.